Ipilimumab Monotherapy for Patients with Melanoma and Brain MetastasesIpilimumab Monotherapy for Patients with Melanoma and Brain Metastases
Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with Jedd D Wolchok, MD, PhD (6/16/10), Steven J O’Day, MD (6/25/10) and David F McDermott, MD (6/25/10)
Lawrence DP et al. Phase II trial of ipilimumab monotherapy in melanoma patients with brain metastases. Proc ASCO 2010;Abstract 8523. |